Cargando…

Bacterial microbiome of lungs in COPD

Chronic obstructive pulmonary disease (COPD) is currently the third leading cause of death in the world. Although smoking is the main risk factor for this disease, only a minority of smokers develop COPD. Why this happens is largely unknown. Recent discoveries by the human microbiome project have sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sze, Marc A, Hogg, James C, Sin, Don D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937108/ https://www.ncbi.nlm.nih.gov/pubmed/24591822 http://dx.doi.org/10.2147/COPD.S38932

Ejemplares similares

A Comparison between Droplet Digital and Quantitative PCR in the Analysis of Bacterial 16S Load in Lung Tissue Samples from Control and COPD GOLD 2
por: Sze, Marc A., et al.
Publicado: (2014)

Changes in the Bacterial Microbiota in Gut, Blood, and Lungs following Acute LPS Instillation into Mice Lungs
por: Sze, Marc A., et al.
Publicado: (2014)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

Lung inflammation in COPD: why does it matter?
por: Oh, Jin Young, et al.
Publicado: (2012)

Lung and Gut Microbiome in COPD
por: Karakasidis, Efstathios, et al.
Publicado: (2023)

Loss of GD1-positive Lactobacillus correlates with inflammation in human lungs with COPD
por: Sze, Marc A, et al.
Publicado: (2015)

Sex differences in lymphoid follicles in COPD airways
por: Tam, Anthony, et al.
Publicado: (2020)

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
por: Mayhew, David, et al.
Publicado: (2018)

Asthma-COPD Overlap Syndrome: What We Know and What We Don't
por: Sin, Don D.
Publicado: (2017)

The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs
por: O’Shaughnessy, Megan, et al.
Publicado: (2023)

Potential role of stem cells in management of COPD
por: Hackett, Tillie L, et al.
Publicado: (2010)

The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions
por: Millares, Laura, et al.
Publicado: (2022)

Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD
por: Erb-Downward, John R., et al.
Publicado: (2011)

Computed tomography total airway count predicts progression to COPD in at-risk smokers
por: Kirby, Miranda, et al.
Publicado: (2021)

Chronic Obstructive Pulmonary Disease and the Airway Microbiome: What Respirologists Need to Know
por: Sin, Don D.
Publicado: (2023)

The cellular and molecular determinants of emphysematous destruction in COPD
por: Suzuki, Masaru, et al.
Publicado: (2017)

COVID-19 in COPD: A growing concern
por: Sin, Don D.
Publicado: (2020)

Diet and COPD: Are we what we eat?
por: Sin, Don D.
Publicado: (2019)

The consequence of matrix dysfunction on lung immunity and the microbiome in COPD
por: Hussell, Tracy, et al.
Publicado: (2018)

Pulmonary Rehabilitation in a Post-COVID-19 World: Telerehabilitation as a New Standard in Patients with COPD
por: Tsutsui, Mai, et al.
Publicado: (2021)

The bronchial epithelial cell bacterial microbiome and host response in patients infected with human immunodeficiency virus
por: Sze, Marc A., et al.
Publicado: (2016)

Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial
por: Mohan, Divya, et al.
Publicado: (2021)

COVID-19 and COPD
por: Leung, Janice M., et al.
Publicado: (2020)

Update on Asthma–COPD Overlap (ACO): A Narrative Review
por: Mekov, Evgeni, et al.
Publicado: (2021)

Budesonide/Formoterol Enhances the Expression of Pro Surfactant Protein-B in Lungs of COPD Patients
por: Um, Soo Jung, et al.
Publicado: (2013)

Distinct bronchial microbiome precedes clinical diagnosis of lung cancer
por: Marshall, Erin A., et al.
Publicado: (2022)

Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa
por: Goolam Mahomed, T., et al.
Publicado: (2021)

Effect of gene environment interactions on lung function and cardiovascular disease in COPD
por: Hackett, Tillie-Louise, et al.
Publicado: (2011)

Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study
por: Sin, Don D, et al.
Publicado: (2007)

Longer Telomere Length in COPD Patients with α(1)-Antitrypsin Deficiency Independent of Lung Function
por: Saferali, Aabida, et al.
Publicado: (2014)

SP-D Polymorphisms and the Risk of COPD
por: Shakoori, Tania A., et al.
Publicado: (2012)

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
por: Agusti, Alvar, et al.
Publicado: (2023)

The diagnostic performance of patient symptoms in screening for COPD
por: Johnson, Kate M., et al.
Publicado: (2018)

The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study
por: Leung, Clarus, et al.
Publicado: (2021)

Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort
por: Park, Hye Yun, et al.
Publicado: (2018)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

No room to breathe: the importance of lung hyperinflation in COPD
por: Thomas, Mike, et al.
Publicado: (2013)

A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation
por: Chen, Yu-Wei Roy, et al.
Publicado: (2016)

Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome
por: Engel, Marion, et al.
Publicado: (2017)

The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients
por: Kim, Hyun Jung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eesnmit0ok3rriivht9dq51a4j